Pfizer(US:PFE) Zhi Tong Cai Jing·2025-11-19 03:05Core Viewpoint - Pfizer (PFE.US) plans to raise at least $5 billion through the issuance of dollar-denominated corporate bonds, partly to finance the recent acquisition of obesity drug developer Metsera [1] Group 1: Bond Issuance Details - Pfizer intends to issue bonds in up to seven tranches, with the longest being a 40-year bond initially priced at a premium of approximately 1.25 percentage points over U.S. Treasury yields [1] - On the day of the announcement, Pfizer, along with eight other institutions, initiated an investment-grade bond issuance [1] Group 2: Acquisition and Financing - Pfizer completed the acquisition of Metsera for a total consideration of up to $10 billion, which includes an additional cash payment of $20.65 per share linked to contingent value rights [1] - The funds raised from the bond issuance will also be used for general corporate purposes and to refinance existing debt [1]